Q4 2024 Earnings Call Transcript March 12, 2025 InspireMD, Inc. beats earnings expectations. Reported EPS is $-0.18, ...

InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Prime carotid stent system for the treatment of carotid artery disease and prevention of stroke, today ...

Management to host investor conference call today, March 12th, at 8:30am ETMIAMI, March 12, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Prime carotid stent system ...

The following is a summary of "Cerebral Hyperperfusion Syndrome After Carotid Revascularization; Predictors and Complications," published in the March 2025 issue of the Annals of Vascular Surgery by ...

Testimonials from initial use of the TREO FIT physician-modified endovascular graft highlight the system’s potential for ...

The operation can be performed one of two ways: a less invasive procedure called carotid angioplasty and stenting, which involves a surgeon inserting a catheter through a blood vessel in the neck or ...

Carotid artery disease, a progressive buildup of calcium deposits and cholesterol in the primary artery supplying blood to the brain, poses a risk of stroke but there are a few ways to treat it. Dr.

The inducement plan is used exclusively for the grant of equity awards to individuals who were not previously employees of InspireMD, or following a bona fide period of non-employment, as an ...

According to the company, the trial evaluated the company’s River venous sinus stent for the treatment of idiopathic intracranial hypertension (IIH) in patients who are refractory or intolerant to ...